I. Costa

Biomarkers in Leishmaniasis: From Basic Research to Clinical Application

N. Santarém, A. Cordeiro-da-Silva, Sofia Esteves, 2018, Biomarker - Indicator of Abnormal Physiological Process.

Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination

R. Guiomar, A. P. Rodrigues, I. Kislaya, 2022, Vaccines.

High correlation between binding IgG (anti-RBD/S) and neutralizing antibodies against SARS-CoV-2 six months after vaccination

J. Aguiar, A. S. Silva, A. Graça, 2021, medRxiv.

Antimalarial Agents as Therapeutic Tools Against Toxoplasmosis—A Short Bridge between Two Distant Illnesses

M. L. Cristiano, P. O’Neill, I. Costa, 2020, Molecules.

Synthesis, Structure and Antileishmanial Evaluation of Endoperoxide–Pyrazole Hybrids

Ricardo F. Mendes, M. L. Cristiano, S. Cortes, 2022, Molecules.

IL-2 and IFN- are biomarkers of SARS-CoV-2 specific cellular response in whole blood stimulation assays

Vitor B. Pinheiro, N. Santarém, J. Tavares, 2021, medRxiv.

Use of Antigen Combinations to Address Complex Leishmania-Seropositivity Patterns in Dogs Living in Canine Leishmaniosis Endemic Regions of Portugal

N. Santarém, L. Cardoso, A. Cordeiro-da-Silva, 2022, Microorganisms.

Leishmania Vesicle-Depleted Exoproteome: What, Why, and How?

N. Santarém, A. Cordeiro-da-Silva, Sofia Esteves, 2022, Microorganisms.

Characterization and Proteomic Analysis of Plasma EVs Recovered from Healthy and Diseased Dogs with Canine Leishmaniosis

C. Fernández-Becerra, N. Santarém, A. Cordeiro-da-Silva, 2023, International Journal of Molecular Sciences.